TNF Pharmaceuticals (TNFA) Competitors $3.40 -0.21 (-5.82%) As of 01:39 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. PWUP, DRMA, GTBP, JAGX, VAXX, BDRX, SHPH, CNSP, GRI, and PRFXShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include PowerUp Acquisition (PWUP), Dermata Therapeutics (DRMA), GT Biopharma (GTBP), Jaguar Animal Health (JAGX), Vaxxinity (VAXX), Biodexa Pharmaceuticals (BDRX), Shuttle Pharmaceuticals (SHPH), CNS Pharmaceuticals (CNSP), GRI Bio (GRI), and PainReform (PRFX). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors PowerUp Acquisition Dermata Therapeutics GT Biopharma Jaguar Animal Health Vaxxinity Biodexa Pharmaceuticals Shuttle Pharmaceuticals CNS Pharmaceuticals GRI Bio PainReform PowerUp Acquisition (NASDAQ:PWUP) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, media sentiment, profitability, institutional ownership, valuation, earnings, analyst recommendations and dividends. Does the media prefer PWUP or TNFA? In the previous week, TNF Pharmaceuticals had 6 more articles in the media than PowerUp Acquisition. MarketBeat recorded 6 mentions for TNF Pharmaceuticals and 0 mentions for PowerUp Acquisition. TNF Pharmaceuticals' average media sentiment score of 0.35 beat PowerUp Acquisition's score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment PowerUp Acquisition Neutral TNF Pharmaceuticals Neutral Which has more volatility & risk, PWUP or TNFA? PowerUp Acquisition has a beta of 0.05, suggesting that its share price is 95% less volatile than the S&P 500. Comparatively, TNF Pharmaceuticals has a beta of 2.04, suggesting that its share price is 104% more volatile than the S&P 500. Do insiders and institutionals believe in PWUP or TNFA? 19.2% of PowerUp Acquisition shares are owned by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 48.0% of PowerUp Acquisition shares are owned by company insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is PWUP or TNFA more profitable? PowerUp Acquisition's return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets PowerUp AcquisitionN/A N/A N/A TNF Pharmaceuticals N/A -69.21%-33.98% Which has better valuation & earnings, PWUP or TNFA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPowerUp AcquisitionN/AN/AN/AN/AN/ATNF PharmaceuticalsN/AN/A-$23.36M-$2.31-1.48 SummaryPowerUp Acquisition beats TNF Pharmaceuticals on 4 of the 7 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.12M$2.64B$5.78B$9.92BDividend YieldN/A49.35%6.67%4.51%P/E Ratio-0.0123.2775.8626.67Price / SalesN/A735.25556.21121.26Price / CashN/A169.7737.1158.92Price / Book0.015.4511.436.07Net Income-$23.36M$32.95M$3.29B$266.42M7 Day Performance-29.19%2.00%0.61%0.04%1 Month Performance-67.43%6.91%6.90%3.92%1 Year PerformanceN/A0.48%59.44%23.82% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$3.40-5.8%N/AN/A$6.10MN/A-0.016News CoverageStock SplitGap DownPWUPPowerUp AcquisitionN/A$0.55+1.7%N/A-94.8%$4.24MN/A0.00N/AGap DownHigh Trading VolumeDRMADermata Therapeutics2.1617 of 5 stars$5.76+5.0%$10.00+73.8%-63.6%$4.01MN/A-0.368Short Interest ↑GTBPGT Biopharma2.4826 of 5 stars$1.13+1.8%$11.00+873.5%-57.4%$3.99MN/A-0.288News CoverageJAGXJaguar Animal Health2.9899 of 5 stars$1.79-0.3%$60.00+3,261.3%-94.1%$3.90M$11.69M0.0050Short Interest ↓Gap UpVAXXVaxxinityN/A$0.03+200.0%N/A+3,900.0%$3.80MN/A-0.0790Gap DownBDRXBiodexa Pharmaceuticals0.6247 of 5 stars$6.09-2.0%N/AN/A$3.77MN/A0.0020Short Interest ↓Gap DownSHPHShuttle Pharmaceuticals0.6564 of 5 stars$3.34+0.6%N/A-94.2%$3.63MN/A-0.825CNSPCNS Pharmaceuticals1.8276 of 5 stars$6.40-1.3%$300.00+4,591.2%-93.2%$3.60MN/A0.005Gap DownGRIGRI Bio3.2987 of 5 stars$1.40-2.8%$22.00+1,471.4%-82.6%$3.53MN/A-0.121News CoverageShort Interest ↓Gap DownPRFXPainReform0.8844 of 5 stars$1.72-1.4%N/A+88.9%$3.45MN/A-0.014 Related Companies and Tools Related Companies PowerUp Acquisition Alternatives Dermata Therapeutics Alternatives GT Biopharma Alternatives Jaguar Animal Health Alternatives Vaxxinity Alternatives Biodexa Pharmaceuticals Alternatives Shuttle Pharmaceuticals Alternatives CNS Pharmaceuticals Alternatives GRI Bio Alternatives PainReform Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
